MissionIR Articles
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present, Share Highlights at Emerging Growth Conference
Pressure BioSciences (OTCQB: PBIO) has announced its CEO will be participating in the upcoming Emerging Growth Conference. PBIO is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Executes LOI to Acquire Global Eco-Friendly Agrochemical Supplier
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, has…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses Measurable Progress on The Stock Day Podcast
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, was featured on a…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates to Advance Commercialization of Patented UST Platform
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, together with the College of Food, Agricultural and Environmental Sciences (“CFAES”) at Ohio State University, recently…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Talks About Recent Formation of Food Industry Consortium in “Emerging Technology Insider” Video
Pressure BioSciences (OTCQB: PBIO) (“PBI”) founder, president and CEO Ric Schumacher was a guest on a recent episode of “Emerging Technology Insider,” which regularly releases video conversations with management of technology companies with business or…
-
Pressure BioSciences, Inc. (PBIO) and Ohio State University Form Food Industry Consortium to Advance Commercialization of PBIO’s Patented Ultra Shear Technology(TM) Platform
High Pressure Processing (“HPP”) has become a highly successful method to reduce pathogens and extend shelf-life in food and beverages while maintaining taste, nutrition, flavor, and texture The HPP food and beverage market was estimated…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Academia-Industry Partnership with The Ohio State University
Pressure BioSciences (OTCQB: PBIO) has entered into an agreement with the College of Food, Agricultural, and Environmental Sciences (“CFAES”) at The Ohio State University; the agreement has myriad objectives, including supporting improvements in PBI’s (“PBI”) Ultra…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Lucrative Eco-Friendly Agrochemical Market
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, has set in motion plans to purchase the assets of an internationally-based, eco-friendly agrochemical developer. An article…
-
Pressure BioSciences, Inc. (PBIO) Announces Plans to Acquire the Assets of Global Eco-Friendly Agrochemical Supplier
Pressure BioSciences to acquire the assets of a global, eco-friendly agrochemical supplier for worldwide distribution into food production markets Assets include formulations, manufacturer relationships, trademarks and other IP, registrations, licenses, and access to distributors and…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced its entry into…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Collaboration to Evaluate Feasibility of Ultra Shear Technology Platform to Improve Effectiveness of SinuSys Lead Product Candidate
Pressure BioSciences (OTCQB: PBIO), today announced a collaboration with SinuSys Corporation aimed at evauating the potential for PBI’s innovative Ultra Shear Technology(TM) (“UST”) platform to strengthen the effectiveness of SinuSys Corp’s lead product candidate Restora. Depending…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Selected as ‘Method of Choice’ for Many Global Research Teams
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced a remarkable convergence of global research teams…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Slated to Present at Leading Investor Forum
Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at the upcoming Life Sciences Investor Forum (“LSIF”). The leading proprietary investor conference is scheduled for Dec. 17, 2020, and is a live, interactive investor…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) on Track to Launch BaroShear K45 Nanoemulsification System in 2021
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Looks to Provide Key to Commercial Success of Novel Products
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded First US Patent for Revolutionary UST(TM) Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Path to Commercialization Targets Multibillion Hemp-Derived CBD Market
Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process…
-
Pressure BioSciences (PBIO) Achieves Critical Milestone in Commercial Rollout of Revolutionary Nanoemulsification System
Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field PBIO is developing a novel high pressure…
-
MissionIRNewsBreaks – Pressure BioSciences (PBIO) Locks In Final System Design, Begins Production of Alpha Unit
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, has reached what it calls as…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded Key Patent for Critical Addition to Instruments, Consumables Product Line
Pressure BioSciences (OTCQB: PBIO) recently announced its receipt of a pivotal U.S. patent for “Sample Preparation Devices and Methods,” which expands its already significant intellectual property (“IP”) portfolio. This award increases Pressure BioSciences’ IP ownership…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option